You are on the TAC legacy website. Please visit our new website: www.tac.org.za

Pharmaceutical Companies

warning: Creating default object from empty value in /usr/www/users/tacaor/public_site/community/modules/taxonomy/taxonomy.pages.inc on line 34.
Printer-friendly version

Wrong-doings of Matthias Rath

Rulings and criticisms against Matthias Rath

The Advertising Standards Authority of South Africa (ASASA) has ordered Rath to withdraw his unsubstantiated claims following a complaint by TAC. 
http://www.tac.org.za/newsletter/2005/ns14_03_2005.htm#asasa
There are three ASASA rulings against Rath. They can be found here.

The British Advertising Standards Authority has forced Rath to remove his advertising for treatments as they were unsupported by evidence and misled the public.
http://www.tac.org.za/documents/BritishASARulingAgainstRath.pdf

The Food and Drug Administration in the USA has cautioned Rath for advertising some of his products in contravention of US law. 
http://www.fda.gov/cder/warn/cyber/2002/CFSANvitacor.htm

TAC complains to the Competition Commission about the anti-competitive conduct of the world's largest pharmaceutical company

 Contents:

  • TAC lodges complaint against MSD and Merck over failure to license key antiretroviral drug, efavirenz, on reasonable terms.
  • Full complaint is available at:

TAC Electronic Newsletter

 Contents

 

  • TAC demands better antiretroviral rollout in Mpumalanga hospitals

  • Letter from Physicians for Human Right to President Mbeki

Open Letter to the Pharmaceutical Manufacturers

 

 
TAC - HIV & AIDS Treatment Action Campaign
PO Box 31104, Braamfontein 2017,Tel:
011-403 0265 Facsimile: 011 - 403 2106
Email: shasha@netactive.co.za

 

Syndicate content